No Appeal of LDT/FDA Lawsuit

No Appeal of LDT/FDA Lawsuit

The FDA had until May 30 to appeal U.S. District Court Judge Sean D. Jordan's decision to vacate the agency's Final Rule seeking to regulate laboratory developed tests (LDTs). The federal government declined to appeal the judge's decision meaning the Texas District Court's decision to vacate, in its entirety, the FDA's attempt to regulate LDTs as medical devices stands.

Read ACLA’s full lawsuit.

Read the Final Judgment.

 

Recent Congressional Actions Seek to Address Medicare LCD, MA, and NSA Enforcement Reforms

Recent Congressional Actions Seek to Address Medicare LCD, MA, and NSA Enforcement Reforms

A suite of bills recently introduced in Congress seek to address issues underlying Medicare local coverage determinations (LCDs), Medicare Advantage...

Read More
Medicare MBI Changes: What Providers Need to Know to Prevent Claim Denials

Medicare MBI Changes: What Providers Need to Know to Prevent Claim Denials

TELCOR has noticed an increase in “missing/incomplete/invalid patient identifier” denials from Medicare.

Read More